Showing results (31-40 of 77) with videos related to
Sort By:
Pageof 8
Journal of Neurology, Neurosurgery, and Psychiatry|July 1, 2019
Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settingsAndreas A Argyriou, Susanna B Park, Badrul Islam, et al.Parkinsonism & Related Disorders|March 5, 2013
Peripheral neuropathy in Parkinson's disease: levodopa exposure and implications for duodenal deliveryThomas Müller, Teus van Laar, David R Cornblath, et al.Journal of the Peripheral Nervous System : JPNS|March 10, 2022
Analysis of relapse by inflammatory Rasch-built overall disability scale status in the PATH study of subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathyIngemar S J Merkies, Ivo N van Schaik, Vera Bril, et al.Archives of Neurology|August 10, 2005
Supportive care for patients with Guillain-Barré syndromeRichard A C Hughes, Eelco F M Wijdicks, Estelle Benson, et al.Trials|July 27, 2016
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trialIvo N van Schaik, Nan van Geloven, Vera Bril, et al.European Journal of Neurology|September 16, 2024
Repurposing chemotherapy-induced peripheral neuropathy gradingRoser Velasco, Andreas A Argyriou, David R Cornblath, et al.Journal of Neurology, Neurosurgery, and Psychiatry|December 23, 2016
Differentiating lower motor neuron syndromesNidhi Garg, Susanna B Park, Steve Vucic, et al.Journal of the Peripheral Nervous System : JPNS|July 7, 2020
Placebo effect in chronic inflammatory demyelinating polyneuropathy: The PATH study and a systematic reviewRichard A Lewis, David R Cornblath, Hans-Peter Hartung, et al.Journal of the Peripheral Nervous System : JPNS|March 13, 2016
Does ability to walk reflect general functionality in inflammatory neuropathies?Thomas H P Draak, Kenneth C Gorson, Els K Vanhoutte, et al.Journal of the Peripheral Nervous System : JPNS|January 24, 2019
Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre-randomization phase of the Polyneuropathy And Treatment with Hizentra studyOrell Mielke, Vera Bril, David R Cornblath, et al.Pageof 8